Jacob M. Keaton,Zoha Kamali,Tian Xie,Ahmad Vaez,Ariel Williams,Slavina B. Goleva,Alireza Ani,Evangelos Evangelou,Jacklyn N. Hellwege,Loic Yengo,William J. Young,Matthew Traylor,Ayush Giri,Zhili Zheng,Jian Zeng,Daniel I. Chasman,Andrew P. Morris,Mark J. Caulfield,Shih-Jen Hwang,Jaspal S. Kooner,David Conen,John R. Attia,Alanna C. Morrison,Ruth J. F. Loos,Kati Kristiansson,Reinhold Schmidt,Andrew A. Hicks,Peter P. Pramstaller,Christopher P. Nelson,Nilesh J. Samani,Lorenz Risch,Ulf Gyllensten,Olle Melander,Harriette Riese,James F. Wilson,Harry Campbell,Stephen S. Rich,Bruce M. Psaty,Yingchang Lu,Jerome I. Rotter,Xiuqing Guo,Kenneth M. Rice,Peter Vollenweider,Johan Sundström,Claudia Langenberg,Martin D. Tobin,Vilmantas Giedraitis,Jian’an Luan,Jaakko Tuomilehto,Zoltan Kutalik,Samuli Ripatti,Veikko Salomaa,Giorgia Girotto,Stella Trompet,J. Wouter Jukema,Pim van der Harst,Paul M. Ridker,Franco Giulianini,Veronique Vitart,Anuj Goel,Hugh Watkins,Sarah E. Harris,Ian J. Deary,Peter J. van der Most,Albertine J. Oldehinkel,Bernard D. Keavney,Caroline Hayward,Archie Campbell,Michael Boehnke,Laura J. Scott,Thibaud Boutin,Chrysovalanto Mamasoula,Marjo-Riitta Järvelin,Annette Peters,Christian Gieger,Edward G. Lakatta,Francesco Cucca,Jennie Hui,Paul Knekt,Stefan Enroth,Martin H. De Borst,Ozren Polašek,Maria Pina Concas,Eulalia Catamo,Massimiliano Cocca,Ruifang Li-Gao,Edith Hofer,Helena Schmidt,Beatrice Spedicati,Melanie Waldenberger,David P. Strachan,Maris Laan,Alexander Teumer,Marcus Dörr,Vilmundur Gudnason,James P. Cook,Daniela Ruggiero,Ivana Kolcic,Eric Boerwinkle,Michela Traglia,Terho Lehtimäki,Olli T. Raitakari,Andrew D. Johnson,Christopher Newton-Cheh,Morris J. Brown,Anna F. Dominiczak,Peter J. Sever,Neil Poulter,John C. Chambers,Roberto Elosua,David Siscovick,Tõnu Esko,Andres Metspalu,Rona J. Strawbridge,Markku Laakso,Anders Hamsten,Jouke-Jan Hottenga,Eco de Geus,Andrew D. Morris,Colin N. A. Palmer,Ilja M. Nolte,Yuri Milaneschi,Jonathan Marten,Alan Wright,Eleftheria Zeggini,Joanna M. M. Howson,Christopher J. O’Donnell,Tim Spector,Mike A. Nalls,Eleanor M. Simonsick,Yongmei Liu,Cornelia M. van Duijn,Adam S. Butterworth,John N. Danesh,Cristina Menni,Nicholas J. Wareham,Kay-Tee Khaw,Yan V. Sun,Peter W. F. Wilson,Kelly Cho,Peter M. Visscher,Joshua C. Denny,Cornelia M. van Duijn,Adam S. Butterworth,Ahmad Vaez,Alexander Teumer,Andrew D. Johnson,Andrew D. Morris,Annette Peters,Anuj Goel,Archie Campbell,Bernard D. Keavney,Caroline Hayward,Christopher Newton-Cheh,Christopher P. Nelson,Daniel I. Chasman,Daniel Levy,Daniela Ruggiero,Eco de Geus,Edith Hofer,Eleftheria Zeggini,Eric Boerwinkle,Giorgia Girotto,Helen R. Warren,Hugh Watkins,Ivana Kolcic,J. Wouter Jukema,Jennie Hui,Joanna M. M. Howson,Johan Sundström,John C. Chambers,John N. Danesh,Lorenz Risch,Mark J. Caulfield,Markku Laakso,Martin D. Tobin,Martin H. De Borst,Melanie Waldenberger,Nilesh J. Samani,Olle Melander,Olli T. Raitakari,Ozren Polašek,Patricia B. Munroe,Paul M. Ridker,Pim van der Harst,Roberto Elosua,Samuli Ripatti,Terho Lehtimäki,William J. Young,Zoha Kamali,Zoltan Kutalik,Daniel Levy,Todd L. Edwards,Patricia B. Munroe,Harold Snieder,Helen R. Warren,Million Veteran Program,Lifelines Cohort Study,CHARGE consortium,ICBP Consortium

Abstract:Hypertension affects more than one billion people worldwide. Here we identify 113 novel loci, reporting a total of 2,103 independent genetic signals ( P < 5 × 10 −8 ) from the largest single-stage blood pressure (BP) genome-wide association study to date ( n = 1,028,980 European individuals). These associations explain more than 60% of single nucleotide polymorphism-based BP heritability. Comparing top versus bottom deciles of polygenic risk scores (PRSs) reveals clinically meaningful differences in BP (16.9 mmHg systolic BP, 95% CI, 15.5–18.2 mmHg, P = 2.22 × 10 −126 ) and more than a sevenfold higher odds of hypertension risk (odds ratio, 7.33; 95% CI, 5.54–9.70; P = 4.13 × 10 −44 ) in an independent dataset. Adding PRS into hypertension-prediction models increased the area under the receiver operating characteristic curve (AUROC) from 0.791 (95% CI, 0.781–0.801) to 0.826 (95% CI, 0.817–0.836, ∆AUROC, 0.035, P = 1.98 × 10 −34 ). We compare the 2,103 loci results in non-European ancestries and show significant PRS associations in a large African-American sample. Secondary analyses implicate 500 genes previously unreported for BP. Our study highlights the role of increasingly large genomic studies for precision health research.

Machine learning models for predicting blood pressure phenotypes by combining multiple polygenic risk scores

Evaluating the use of blood pressure polygenic risk scores across race/ethnic background groups

Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits

Optimization of Multi-Ancestry Polygenic Risk Score Disease Prediction Models

Life-Course Associations between Blood Pressure-Related Polygenic Risk Scores and Hypertension in the Bogalusa Heart Study

Identifying and characterizing disease subpopulations that most benefit from polygenic risk scores

Abstract 040: Comparative Genomic Analysis and Functional Insights for Blood Pressure-Associated Single Nucleotide Polymorphisms

A Machine Learning Model for Disease Risk Prediction by Integrating Genetic and Non-Genetic Factors

A comprehensive investigation of statistical and machine learning approaches for predicting complex human diseases on genomic variants

Genomic Prediction of 16 Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer

Clinical use of polygenic risk scores for detection of peripheral artery disease and cardiovascular events

Machine Learning Prediction of Biomarkers from SNPs and of Disease Risk from Biomarkers in the UK Biobank

Polygenic risk scores for the prediction of cardiometabolic disease

Abstract 8: Polygenic Resistance to Blood Pressure Treatment and Stroke Risk

Genome-wide pleiotropy analysis identifies novel blood pressure variants and improves its polygenic risk scores

Association of a Multiancestry Genome-Wide Blood Pressure Polygenic Risk Score With Adverse Cardiovascular Events

Deep Learning for Polygenic Risk Prediction

A Prediction Model of Essential Hypertension Based on Genetic and Environmental Risk Factors in Northern Han Chinese

Genomic Prediction of Complex Disease Risk

Using Machine Learning to Evaluate the Value of Genetic Liabilities in the Classification of Hypertension within the UK Biobank

Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers